Computational analyses of Fe-Chelation by thiofavipiravir

Author:

Rajabzadeh Halimeh1,Abbasi Maryam2ORCID,Tohoidian Mostafa3

Affiliation:

1. Department of Chemistry, Dezful Branch, Islamic Azad University, Dezful, Iran

2. Department of Chemistry, Payame Noor University, Tehran, Iran

3. Department of Pharmaceutics, Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract

Existence of iron (Fe) is important for cells of living systems; however, its level of magnitude for those patients infected by novel coronavirus disease (COVID-19) is still a challenging issue. Therefore, such mechanism of function was investigated in this work by assistance of thiofavipiravir (TFav) compounds generated by the well-known favipiravir (Fav) drug used for medication of COVID-19 patents. To this aim, sulfur-substitutions of oxygen atoms of Fav were done and the obtained parent structures were prepared for participating in Fe-chelation function. The results indicated that the modes were suitable for running such Fe-chelation processes, in which favorability and strength the models were ranged in this order: 1O2S-Fe >  1S2S-Fe >  1O2O-Fe >  1S2O-Fe. As a consequence, such idea of sulfur-substitution of Fav drug for more appropriate favorability of participating in Fe-chelation process was sensed by results of this work proposing 1O2S compound as the most favorable one for doing the function. Hence, information about capability of TFav compounds for participating in Fe-chelation processes were provided in this work regarding the challenging issue of Fe-chelation in medication of COVID-19 patients. All results of this work were obtained by performing computations using the density functional theory (DFT) approach

Publisher

IOS Press

Subject

Materials Chemistry,Inorganic Chemistry,Organic Chemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3